Chimeric Antigen Reception (CAR) T-cell Therapy Market Global Scenario, Market Size, Outlook, Trend, and Forecast, 2019 – 2028

TABLE OF CONTENTS

Chapter 1        Prefix

1.1    Market Scope

1.2    Report Description

1.3    Research Methodology

1.3.1      Primary Research

1.3.2      Secondary Research

1.3.3      In-house Data Modeling

Chapter 2        Executive Summary

2.1   Global Chimeric Antigen Reception (CAR) T-cell Therapy Market Year-on-Year Growth, 2020 - 2028 (%)

Chapter 3        Market Outline

3.1    Market Inclination, Trend, Outlook and Viewpoint

3.2    Market Share Analysis: Company’s Competitive Scenario

3.3    Value Chain Analysis

3.4    Porter’s Five Forces Analysis

3.5    Market Dynamics

3.5.1      Drivers

3.5.1.1      Impact Analysis

3.5.2      Restraints

3.5.2.1      Impact Analysis

3.5.3      Opportunities

Chapter 4        Global Chimeric Antigen Reception (CAR) T-cell Therapy Market by Product Type: Market Size and Forecast, 2019 – 2028

4.1    Overview

4.2  Tisagenleceucel

4.2.1    Current Trend and Analysis

4.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.3  Lisocabtagene Maraleucel

4.3.1    Current Trend and Analysis

4.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.4  Axicabtagene Ciloleucel

4.4.1    Current Trend and Analysis

4.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.5  Brexucabtagene Autoleucel

4.5.1    Current Trend and Analysis

4.5.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.5.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.6  Ideacabtagene Vicleucel

4.6.1    Current Trend and Analysis

4.6.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.6.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

4.7  Others

4.7.1    Current Trend and Analysis

4.7.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

4.7.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 5        Global Chimeric Antigen Reception (CAR) T-cell Therapy Market by Indication: Market Size and Forecast, 2019 – 2028

5.1  Overview

5.2  Acute Lymphocytic Leukemia

5.2.1    Current Trend and Analysis

5.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.2.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.3  Mantle Cell Lymphoma

5.3.1    Current Trend and Analysis

5.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.3.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.4  Follicular Lymphoma

5.4.1    Current Trend and Analysis

5.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.4.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.5  Diffuse Large B- Cell Lymphoma

5.5.1    Current Trend and Analysis

5.5.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.5.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.6  Multiple Myeloma

5.6.1    Current Trend and Analysis

5.6.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.6.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

5.7  Others

5.7.1    Current Trend and Analysis

5.7.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

5.7.3    Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 6        Global Chimeric Antigen Reception (CAR) T-cell Therapy Market by End User: Market Size and Forecast, 2019 – 2028

6.1  Overview

6.2  Cancer Treatment Centers

6.2.1      Current Trend and Analysis

6.2.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.2.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.3  Hospitals

6.3.1      Current Trend and Analysis

6.3.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.3.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

6.4  Others

6.4.1      Current Trend and Analysis

6.4.2      Market Size and Forecast, 2019 - 2028 ($ Billion)

6.4.3      Market Size and Forecast by Region, 2019 - 2028 ($ Billion)

Chapter 7        Global Chimeric Antigen Reception (CAR) T-cell Therapy Market by Geography: Market Size and Forecast, 2019 – 2028

7.1  Overview

7.1.1    Global Chimeric Antigen Reception (CAR) T-cell Therapy Market Year-on-Year Growth, by region 2020 – 2028 (%)

7.2  North America

7.2.1    Current Trend and Analysis

7.2.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3    U.S.

7.2.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.3.2        By Product Type

7.2.3.3        By Indication

7.2.3.4        By End User

7.2.4    Canada

7.2.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.4.2        By Product Type

7.2.4.3        By Indication

7.2.4.4        By End User

7.2.5    Mexico

7.2.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.5.2        By Product Type

7.2.5.3        By Indication

7.2.5.4        By End User

7.2.6    Rest of North America

7.2.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.2.6.2        By Product Type

7.2.6.3        By Indication

7.2.6.4        By End User

7.3    Europe

7.3.1    Current Trend and Analysis

7.3.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3    UK

7.3.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.3.2        By Product Type

7.3.3.3        By Indication

7.3.3.4        By End User

7.3.4    Russia

7.3.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.4.2        By Product Type

7.3.4.3        By Indication

7.3.4.4        By End User

7.3.5    France

7.3.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.5.2        By Product Type

7.3.5.3        By Indication

7.3.5.4        By End User

7.3.6    Italy

7.3.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.6.2        By Product Type

7.3.6.3        By Indication

7.3.6.4        By End User

7.3.7    Germany

7.3.7.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.7.2        By Product Type

7.3.7.3        By Indication

7.3.7.4        By End User

7.3.8    Rest of Europe

7.3.8.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.3.8.2        By Product Type

7.3.8.3        By Indication

7.3.8.4        By End User

7.4    Asia-Pacific

7.4.1    Current Trend and Analysis

7.4.2    Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3    China

7.4.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.3.2        By Product Type

7.4.3.3        By Indication

7.4.3.4        By End User

7.4.4    India

7.4.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.4.2        By Product Type

7.4.4.3        By Indication

7.4.4.4        By End User

7.4.5    Japan

7.4.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.5.2        By Product Type

7.4.5.3        By Indication

7.4.5.4        By End User

7.4.6    Rest of Asia-Pacific

7.4.6.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.4.6.2        By Product Type

7.4.6.3        By Indication

7.4.6.4        By End User

7.5    RoW

7.5.1    Current Trend and Analysis

7.5.2    Market Size and Forecast

7.5.3    South America

7.5.3.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.3.2        By Product Type

7.5.3.3        By Indication

7.5.3.4        By End User

7.5.4    Middle East

7.5.4.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.4.2        By Product Type

7.5.4.3        By Indication

7.5.4.4        By End User

7.5.5    Africa

7.5.5.1        Market Size and Forecast, 2019 - 2028 ($ Billion)

7.5.5.2        By Product Type

7.5.5.3        By Indication

7.5.5.4        By End User

Chapter 8        Company Profiles

8.1  Bristol-Myers Squibb

8.1.1      Company Overview

8.1.2      Product Portfolio

8.1.3      Business Strategies

8.1.4      Financials

8.1.5          Recent Developments

8.2  Gilead Sciences Inc.

8.2.1      Company Overview

8.2.2      Product Portfolio

8.2.3      Business Strategies

8.2.4      Financials

8.2.5          Recent Developments

8.3  Sorrento Therapeutics Inc.

8.3.1      Company Overview

8.3.2      Product Portfolio

8.3.3      Business Strategies

8.3.4      Financials

8.3.5          Recent Developments

8.4  Amgen Inc.

8.4.1      Company Overview

8.4.2      Product Portfolio

8.4.3      Business Strategies

8.4.4      Financials

8.4.5          Recent Developments

8.5  Novartis AG

8.5.1      Company Overview

8.5.2      Product Portfolio

8.5.3      Business Strategies

8.5.4      Financials

8.5.5          Recent Developments

8.6  Bluebird Bio Inc.

8.6.1      Company Overview

8.6.2      Product Portfolio

8.6.3      Business Strategies

8.6.4      Financials

8.6.5          Recent Developments

8.7  Johnson & Johnson

8.7.1      Company Overview

8.7.2      Product Portfolio

8.7.3      Business Strategies

8.7.4      Financials

8.7.5          Recent Developments

8.8  Merck & Co. Inc.

8.8.1      Company Overview

8.8.2      Product Portfolio

8.8.3      Business Strategies

8.8.4      Financials

8.8.5          Recent Developments

8.9  Pfizer

8.9.1      Company Overview

8.9.2      Product Portfolio

8.9.3      Business Strategies

8.9.4      Financials

8.9.5          Recent Developments